STATE STREET CORP - REPROS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of REPROS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$9,000
+125.0%
13,5510.0%0.00%
Q3 2017$4,000
-33.3%
13,5510.0%0.00%
Q2 2017$6,000
-62.5%
13,5510.0%0.00%
Q1 2017$16,000
-15.8%
13,5510.0%0.00%
Q4 2016$19,000
-34.5%
13,551
-2.2%
0.00%
Q3 2016$29,000
+38.1%
13,8510.0%0.00%
Q2 2016$21,000
+61.5%
13,8510.0%0.00%
Q1 2016$13,000
-18.8%
13,8510.0%0.00%
Q4 2015$16,000
-84.5%
13,8510.0%0.00%
Q3 2015$103,000
-36.0%
13,851
-38.6%
0.00%
Q2 2015$161,000
-94.8%
22,551
-93.8%
0.00%
Q1 2015$3,110,000
-13.3%
362,040
+0.7%
0.00%
Q4 2014$3,588,000
-66.8%
359,459
-67.1%
0.00%
-100.0%
Q3 2014$10,818,000
-32.1%
1,092,615
+18.6%
0.00%
-50.0%
Q2 2014$15,937,000
-17.3%
921,128
-15.2%
0.00%0.0%
Q1 2014$19,279,000
-44.7%
1,086,636
-44.0%
0.00%0.0%
Q4 2013$34,854,000
+73.9%
1,940,063
+159.5%
0.00%0.0%
Q3 2013$20,039,000
+282.9%
747,748
+163.6%
0.00%
+100.0%
Q2 2013$5,234,000283,6520.00%
Other shareholders
REPROS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Sarissa Capital Management LP 1,001,000$970,0000.21%
Allegis Investment Advisors, LLC 341,669$331,0000.19%
GENERAL AMERICAN INVESTORS CO INC 396,123$384,0000.04%
Alambic Investment Management, L.P. 114,591$111,0000.04%
Gruss Capital Management LP 600,000$582,0000.02%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 102,086$99,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 323,429$314,0000.01%
GSA CAPITAL PARTNERS LLP 27,931$27,0000.00%
BENJAMIN F. EDWARDS & COMPANY, INC. 2,700$3,0000.00%
Airain ltd 13,690$13,0000.00%
View complete list of REPROS THERAPEUTICS INC shareholders